AMLN - Amylin Pharmaceuticals - Page 10

over reaction?

Maybe, but lately it seems the market is pricing in these huge gap downs pretty accurately.

"FDA requested a thorough QT (tQT) study with exposures of exenatide higher than typical therapeutic levels of BYDUREON. The tQT protocol will be agreed to by the FDA prior to study initiation. Additionally, the FDA has now requested the results of the DURATION-5 study to evaluate the efficacy, and the labeling of the safety and effectiveness, of the commercial formulation of BYDUREON. This letter did not cite any manufacturing processes referenced in the FDA's March 15 complete response letter."

Based on the requirements for additional data, this will likely be considered a Class 2 resubmission requiring a six-month review.


Could be dead money for quite some time. Maybe play the FDA meeting or holding for resubmission PRs.

WOOT go cramer. hit a three run homer!!!!!! Amylin down 50 percent, alkermes down 30 and mankind 6. cant wait to sign up for his service.

Oh thats right, I forgot he pumped it a few days ago.

Looks like they won't resubmit until end of 2011


"On Wednesday, Amylin and Alkermes said they hope to resubmit Bydureon’s application by the end of 2011. "

http://www.marketwatch.com/story/fda...0?siteid=yhoof

ouch -50%!

If you desire to trade pharma, there are much better, cheaper stocks out there. KERX, MYRX, DNDN, etc.

With FDA's play, 50% down is nothing, if U compare to the reward 500-1000%. Death money, but if U didn't sell it, U will get your money back + 200% in 2 years or less

I need to start shorting on FDA dates LOL

finally got their FDA approval

funny how this was rejected ( 3 times ?) in the past, and all of  a sudden, bingo it's okay now...must have figured out the correct bribery procedures this time around.

 

 

First Post! Wow, I've been sitting on AMLN for a while glad to see it spike, but how much longer will this last?

You must be really happy if you still have it today.

lol i wish, I got rid of it on that last surge around 17.

gap 2 even holding up so far

Guys this could be huge.

 

Currently, there are 7 prospective buyers for this company.

Analysts are predicting a potential bidding war concluding in a low-mid $30 range buyout.

Speculation of this news today lead to a 7% increase.

 

There have already been 2 rejected buyouts in the past month, both leading to big gains in PPS.